Mean cumulative lifetime prevalence of eczema 9.9 percent

December 4, 2018

(HealthDay)—The mean cumulative lifetime prevalence of atopic eczema is 9.9 percent, according to a research letter published online Dec. 4 in the Annals of Internal Medicine.

Katrina Abuabara, M.D., from the University of California in Los Angeles, and colleagues estimated the age-specific prevalence of active across the using data from 1994 to 2013 from the Health Improvement Network. They calculated the prevalence of active disease requiring a physician visit or prescription during each year of follow-up.

The researchers found that the cumulative lifetime prevalence of atopic eczema was 9.9 percent among 8,604,333 persons aged 0 to 99 years, with the highest rates of active disease seen among children and . The mean prevalence of active atopic eczema during a given year was 6.9 percent overall and 12.3, 5.1, and 8.7 percent among children aged 0 to 17 years, adults aged 18 to 74 years, and adults aged 75 to 99 years, respectively. Per year, patients received a median of six prescriptions for atopic eczema, including topical steroids and systemic treatments; across , the number of annual prescriptions was similar. Adults aged 18 to 74 years had the highest rates of comorbid atopic disease.

"Rates of active atopic eczema (as defined by diagnosis and treatment codes applied by physicians) increase with age among adults in , addressing a gap in evidence about the epidemiology of this condition after childhood," the authors write.

Explore further: Your severe eczema may best be treated by allergy shots

More information: Abstract/Full Text (subscription or payment may be required

Related Stories

Your severe eczema may best be treated by allergy shots

November 16, 2018
If you've suffered with severe atopic dermatitis (eczema) for a long time and have tried what you think is every available option for relief, you may want to consider allergy shots. A medically-challenging case being presented ...

AD most commonly used term in literature for atopic dermatitis

July 15, 2016
(HealthDay)—Atopic dermatitis (AD) is most commonly referred to as AD in the literature, according to a review published online July 8 in Allergy.

Bee venom may help treat eczema

September 6, 2018
Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis (or eczema), according to a British Journal of Pharmacology study.

Self-reported eczema valid for detecting atopic dermatitis

July 28, 2015
(HealthDay)—Self- and caregiver-reported history of eczema is valid for identifying atopic dermatitis (AD), according to a study published online July 17 in the British Journal of Dermatology.

Study quantifies costs, utilization, access to care for patients with eczema

March 4, 2015
Adults with the common chronic skin condition eczema had higher out-of-pocket health care costs, more lost workdays, poorer overall health, more health care utilization and impaired access to care compared to adults without ...

New treatments help those with mild, moderate and severe eczema

October 27, 2017
If you think only infants suffer from eczema, think again. The uncomfortable, itchy rash that most people relate to babies and young children occurs frequently in adults. Although many adults with atopic dermatitis (commonly ...

Recommended for you

New genetic study could lead to better treatment of severe asthma

December 12, 2018
The largest-ever genetic study of people with moderate-to-severe asthma has revealed new insights into the underlying causes of the disease which could help improve its diagnosis and treatment.

Researchers discover unique immune cell likely drives chronic inflammation

December 11, 2018
For the first time, researchers have identified that an immune cell subset called gamma delta T cells that may be causing and/or perpetuating the systemic inflammation found in normal aging in the general geriatric population ...

Macrophage cells key to helping heart repair—and potentially regenerate, new study finds

December 11, 2018
Scientists at the Peter Munk Cardiac Centre have identified the type of cell key to helping the heart repair and potentially regenerate following a heart attack.

Study identifies a key cellular mechanism that triggers pneumonia in humans

December 11, 2018
The relationship between influenza and pneumonia has long been observed by health workers. Its genetic and cellular mechanisms have now been investigated in depth by scientists in a study involving volunteers and conducted ...

Immune cells sacrifice themselves to protect us from invading bacteria

December 11, 2018
Immune systems are working overtime as winter approaches. Stomach flu can turn the strongest individual into a bedridden convalescent. Viruses are spreading in kindergartens. This year's flu is approaching in full swing. ...

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.